Manufacturing Your First Supplement: A Founder’s Starting Point

Search “how to start a supplement brand” and you get the same article forty times: pick a niche, register an LLC, build a website, find a manufacturer, launch. Buried in the middle is one paragraph on manufacturing and a single made-up total for what it “costs to start.” Then a form.

That order is backwards. Business formation, branding, and a marketing plan all matter, but none of them decides whether your product can be made, what it takes to make it, or how long it runs. The decisions that do are manufacturing decisions, and there are fewer of them than the listicles suggest: five, in a rough order, each one settling the next.

You already own most of the inputs. You know your product, your buyer, and how fast you want to move. What’s new is the manufacturing side: five decisions, in the order a manufacturer actually needs the answers, each pointing to the place that goes deeper. First product or fiftieth SKU, the sequence is the same.

Educational overview: not legal, regulatory, or medical advice. Requirements change and vary by jurisdiction and sales channel. Last reviewed July 2026.

Short answer. Manufacturing your first supplement comes down to five decisions, in order: the format, the path (private label, a formula you own, or custom), the two numbers behind your minimum, the pilot run, and the testing your launch needs. Make those five and you can request a real quote; business entity, branding, and marketing run alongside without holding anything up.

Best for: First-time founders sizing a first production run before requesting quotes.

Key decision: Format and path. They set your minimums, your testing, and your timeline before a single ingredient is named.

Apollo path: A fit review returns a real plan for your exact product from the team that runs the lines in Livermore, California. No finished formula or artwork required to start.

Decision 1: The format, because it cascades the furthest

Format is first because everything downstream inherits it. The format decides the line, the fill method, the component set, where the testing emphasis lands, and part of the timeline, before you’ve named a single ingredient. A 2 oz shot and a 16 oz bottle are different machines, different closures, and different fill behavior. Get the format right and the rest of the decisions get easier; pick it for the wrong reason and you fight it at every later step.

The reason to pick a format is fit: the ingredient and the buyer, not what’s trending. A few honest trade-offs:

• Liquids and functional shots dose flexibly and carry difficult or bitter actives well, and they let a brand stand out on a shelf full of capsules. They ask more of preservation, pH, and stability, and a concentrated liquid makes flavor harder, not easier.
• Capsules and tablets are compact, stable, and familiar, and they carry the lowest component and tooling overhead of the common formats. They fight bulky doses and bitter powders, and they’re a crowded shelf.
• Gummies win on experience and compliance-by-enjoyment, but actives can drift in potency over shelf life, and the format carries heavier component and changeover realities than a capsule.
• Powders and stick packs suit large doses and sampling, and single-serve sticks are a low-friction way to trial a market. Blend uniformity and moisture control are the engineering to get right.

Apollo leads with liquid and runs multiple formats, which makes the honest read simple: choose the format the ingredient and the buyer want, which is sometimes, not always, a liquid. The full format-to-ingredient matrix, including how the same active behaves differently as a gummy, a powder, or a liquid, is laid out in Capsule, Powder, Gummy, or Liquid: Choosing the Right Supplement Format.

Decision 2: The path: private label, your own formula, or custom

Once the format is set, the path decides how the product gets made, and how much of it is yours. Three routes, three different trades between speed, first commitment, and how different your product looks on the shelf.

• Private label a proven base. You brand a formula the manufacturer already owns, usually with light customization and often-stock components. Fastest to market (commonly about four to six weeks) and the lowest first commitment. The trade: the formula isn’t yours, and it may sit behind other brands too.
• Bring a formula you already own. You supply a recipe you hold; the manufacturer reviews the spec, sources components, and runs a pilot. Fast, if you actually own it. Formulas developed under a prior private-label or contract deal often stay with that manufacturer by default, so confirm ownership before you plan a move. That check is worth doing carefully; Who Owns Your Supplement Formula? covers what assignment versus license actually means, and your counsel decides ownership.
• Custom from the bench. You build a new formula with the manufacturer’s R&D team, typically over two to three sample rounds, then a pilot. The highest first commitment and the longest of the three, and the only one that gives you an owned, differentiated formula. How that runs (brief, feasibility, ingredient-interaction work, sample rounds) is in How Custom Supplement Formulation Works.

Neither end is “better.” They’re different trades, and the right one depends on how fast you need to launch versus how much you need a formula that’s only yours. The side-by-side, including which path fits which kind of founder, is in White Label, Private Label, or Custom Formula: Which Path Fits Your Supplement.

Decision 3: The two numbers behind “how many do I have to make?”

This is the decision the listicles get most wrong, so it’s worth slowing down on. Ask “what’s the minimum for my first run?” and most guides hand back one big number: a first batch in the thousands, sometimes tens of thousands. That number conflates two different things with two different owners, and it scares founders out of runs they could actually afford.

Your minimum is two numbers wearing one name:

• The finished-unit run is what the line fills, caps, labels, and packs. This is the number people mean by “small batch,” and it can be small, often in the hundreds of units when compatible materials are on hand. The line does not need thousands to run well.
• The component minimums are what outside suppliers sell (custom labels, bottles, closures, droppers) in the lot sizes they print and mold, commonly in the low thousands. The manufacturer doesn’t set that number; it passes it through. And the excess is yours: you keep it as inventory for the next run.

A quick illustration makes the gap concrete. Say you want a 300-unit pilot of a liquid in a stock 2 oz bottle. The line will fill 300. The smallest practical batch of the blend (the least you can mix and still dose the minor actives accurately and have the batch test true) might come in around 500, so you keep roughly 200 extra filled bottles as sellable stock. Your custom label, though, is a print run with a minimum near 2,000, so you use 300 and bank about 1,700 for later runs. Three different numbers, three different owners. And none of them is the tens-of-thousands wall the guides imply.

Quantities are illustrative; actual component minimums depend on suppliers, format, and what’s on hand.

The move for a founder isn’t to negotiate the big number down. It’s to see the two numbers apart, run stock components where you can, and treat any custom-component excess as pre-bought reorder stock rather than sunk cost. The full worked math (including the three material paths and who owns the excess on each) is in Component Minimums vs. Finished Runs. If you read one deep-dive before requesting a quote, make it that one.

Decision 4: The pilot run, and what it actually proves

A pilot run is a real production run at small scale (often in the hundreds of units, depending on the format and what materials are on hand). It exists for one reason: to prove the formula behaves on production equipment before you commit tooling and a full materials buy.

A sample that passes at the bench can still drift when it scales. Fill weights wander, flavor shifts at volume, a powder segregates, a liquid separates or settles, a blend loses uniformity. Those are the failures that turn into off-spec lots and complaints if the first time you run at scale is also your launch. The pilot surfaces them while they’re cheap to fix. On the custom path, the pilot follows the two to three bench rounds; on private label, a proven base does most of that de-risking already, and a small first run confirms the rest.

Skipping the pilot to save a step is the classic first-timer mistake; it trades a small, controlled run for the risk of discovering a scale problem on the batch you meant to sell. What changes between a bench sample and a full run, and the in-process checks that hold consistency, are covered in From Pilot Batch to Full Production.

Decision 5: The testing your launch actually needs

Testing is where “I made a product” becomes “I have a product I can stand behind.” A launch typically needs identity and potency testing (is the right ingredient in there, at the amount the label claims), heavy-metals and microbial testing (is it clean), and stability testing to support the expiration date you print. The exact scope depends on format and channel; a liquid and a capsule don’t carry the same risks, and an Amazon listing, a retail shelf, and a practitioner line ask for different documentation from the same bottle.

Two things a founder should know about how testing is handled. First, it’s quoted and charged separately from production, coordinated through vetted independent third-party labs, not folded into a single per-unit price. That separation is a feature: it lets you compare quotes honestly and see exactly what each lot was checked for. Second, it produces a per-lot Certificate of Analysis: the document you show a marketplace, a retailer, or a buyer who asks for proof. Learning to read one is a founder skill worth having early; How to Read a Supplement Certificate of Analysis walks through what a strong CoA shows versus a weak one, and What Supplement Testing You Actually Need maps the full stack by stage and channel.

One clarification that saves founders a lot of confusion: as of mid-2026, the FDA does not approve dietary supplements or their labels before they go to market. As the agency states, the companies that manufacture and market supplements are responsible for making sure their products are safe and that label claims are truthful and substantiated. So a facility can be an FDA-registered facility (Apollo’s is), but a finished product is never “FDA-approved,” and any manufacturer claiming otherwise is misrepresenting the framework. The distinction, and why it matters to how you talk about your product, is in FDA-Registered vs. FDA-Approved Supplements.

What to have ready to request a quote

Here’s the part the listicles get backwards by telling you to assemble documents first. You don’t need a finished formula, print-ready artwork, or a testing plan to request a quote. Those get built with the manufacturer. What a fit review needs is five decisions (the same ones above, plus channel and timeline), and you already hold all of them:

1. Where the product stands: an idea, a formula you own, or a running SKU. This decides which team picks it up.
2. The format: liquid, shot, capsule, gummy, powder. This sets the line and the component set.
3. The run size: roughly how many finished units for the first run, and roughly how many a year. A rough figure is fine; it’s what the two numbers land against.
4. The timeline: when you need finished goods in hand, and what’s driving that date.
5. The channel: direct-to-consumer, Amazon, retail, practitioner. This sets the testing scope and the packout.

That’s it. On Apollo’s side, putting the request together takes about 8 to 10 minutes, and the fit review typically comes back in 1 to 2 business days from the people who run the lines: a review, not a commitment. The full logic of what each decision settles on the manufacturer’s end is in How to Prepare for a Manufacturing Quote.

What genuinely comes later, so nothing stalls day one

Half of what founders think is a day-one blocker isn’t. Naming what comes later is how you keep the launch moving instead of stalling on the wrong task:

• Business entity and insurance are real and worth doing, but they run in parallel; they don’t gate a quote or a pilot. Set them up while formulation and sourcing proceed.
• The Supplement Facts panel and label artwork get finalized after the formula and testing lock, because the panel has to match what’s actually in the bottle. Print-ready artwork follows the panel, not the other way around. The label rules that trip up new brands are in Supplement Facts Panels.
• Claim language (the line between “supports healthy energy” and anything that reads as treating a condition) is a compliance decision your counsel owns, not a manufacturing input you need on day one. Get the product made; get the claims reviewed before they go on the label. The taxonomy is in Structure/Function vs Disease Claims.
• Packaging refinement can start on stock and move to custom later; you don’t need custom tooling to launch. The options are in Supplement Packaging Options.
• Fulfillment and FBA prep are the end of the chain, not the front. What marketplace-ready packout involves is in From Bulk to Box: Fulfillment and FBA Prep.
• Reorders are a later problem, and a good one to have; a reorder is faster and simpler than a first run once the formula and components are locked, which is exactly why banked component excess pays off. See Why Reorders Are Faster Than Your First Run.

And the question every guide answers with a fake number: what does this cost? There’s no honest single “cost to start” figure, because it’s the sum of choices you haven’t made yet: format, path, run size, testing scope, and whether your components are stock or custom. What is knowable is what drives the number, and you can read that before you commit to anything: The Costs That Aren’t in Your Manufacturing Quote and Liquid Supplement Manufacturing Cost Drivers lay out the line items and the variables. For how the calendar stacks up (usually weeks to months, not a single lead time), see How Long Does It Take to Manufacture a Supplement?.

The founder’s decision map

Five decisions, in order, each settling something concrete and each with a place that goes deeper. This is the whole starting point on one screen:

Work top to bottom and the sequence does the work: each decision unlocks the next, and every number is one you got to read before you committed to it. That’s the whole advantage of taking the decisions in order. More on the founder path at startups and first products.